Raymond James bullish rating for Bausch Health Companies remains unchanged after a U.S. District Court ruling.

Analysts Doug Cooper and Russel Stanley, in a research update issued April 21, said the reintroduction of the STATES 2.0 Act ...

Good company, bad environment. That’s the takeaway from RBC Dominion Securities analyst Paul Treiber’s latest report on ...

Rohit Kulkarni, Managing Director and Senior Research Analyst at Roth is maintaining his “Buy” rating for Alphabet.

Amr Ezzat, an analyst with Ventum Capital Markets, says Sylogist’s recent US$10.6-million statewide contract win in Texas is ...

In a research update to clients April 9, Beacon analyst Gabriel Leung kept his “Buy” rating on VerticalScope Holdings ...

In a research update to clients April 8th, the analyst maintained his “Outperform” rating and target price of $4.50 per share ...

Dubreuil, ahead of the company’s Q1, 2025 results, due May 8, says a 50% dividend cut is required for BCE to deal with the ...